Reference 2019-717

REF:            2019-717

Subject:        In-patient Vitamin K Antagonists (VKA) dosing/VTE risk assessment practices

    

 

Request:

Freedom of Information Request

 

FOI requests into Trust In-patient Vitamin K Antagonists (VKA) dosing/VTE risk assessment practices

 

 

Does your Trust have an Anticoagulant Service for

In-patients and out-patients  YES

In-patients only  YES   NO

Outpatient only  YES   NO 

 

 

How many inpatient beds does your Trust have (at each site if more than 1 site)?

 

 

a)How many sites do you inpatient dose (if applicable)?

 

 

Who doses VKA for your inpatient population?

 

How many individuals who are not doctors perform this role in the groups specified above

 

 

If you dose warfarin for out-patients, how many warfarin patients do you currently dose?

 

 

Which dosing software do you use – free text

 

 

Does your Trust run nurse led Anticoagulation clinics?

 

 

If there are no nurse led clinics, who is responsible for management of patients taking VKA within your trust

 

 

Who completes your VTE Risk assessments?

 

 

What is your current VTE Risk assessment compliance rate?

 

 

Response:

Please find information attached.

2019-717 – FOI Request – In-patient Vitamin K Antagonists (VKA) dosingVTE risk assessment practices [124 kb] PDF